- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Titan Biotech has informed investors about a special window to facilitate the transfer and dematerialization of physical securities. This one-year window is for shares sold or purchased before April 1, 2019, and also covers prior transfer requests that were rejected. Investors can now convert these physical shares into demat form, securing their ownership. Transferred securities will be subject to a one-year lock-in period. This initiative simplifies the process for shareholders to manage their holdings effectively.